Johnson & Johnson Announces Darren Snellgrove as Vice President, Investor Relations
Portfolio Pulse from
Johnson & Johnson has appointed Darren Snellgrove as Vice President of Investor Relations, effective May 1, 2025. Jessica Moore, the current VP of Investor Relations, will become the Group CFO for Johnson & Johnson's Innovative Medicine division.
March 04, 2025 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson has announced leadership changes with Darren Snellgrove appointed as VP of Investor Relations and Jessica Moore transitioning to Group CFO for Innovative Medicine, effective May 1, 2025.
The appointment of a new VP of Investor Relations and a new Group CFO for Innovative Medicine indicates a strategic leadership shift. However, as these changes are internal and effective in 2025, the immediate impact on stock price is likely neutral.
CONFIDENCE 90
IMPORTANCE 50
RELEVANCE 100